Publication:
A structurationist analysis of differing policies oriented to the pharmaceutical industry: Turkey and Brazil

dc.contributor.authorsYaşgül Y.S.
dc.date.accessioned2022-03-15T02:12:14Z
dc.date.accessioned2026-01-11T08:12:59Z
dc.date.available2022-03-15T02:12:14Z
dc.date.issued2016
dc.description.abstractThis chapter has two purposes closely related to each other. The first one is to analyze why countries that have similar characteristics and benefits to each other develop different strategies in terms of rules that regulate the intellectual property rights in the pharmaceutical industry. The second one is to analyze the factors that determine active participation in global governance processes with regards to the intellectual property rights of countries that are developing, specifically in the pharmaceutical industry. The study used the structurationist approach developed by John M. Hobson, and findings were tested by comparing the examples of two countries: Turkey and Brazil. © 2016 by IGI Global.
dc.identifier.doi10.4018/978-1-4666-9814-7.ch048
dc.identifier.isbn9781466698161; 9781466698154
dc.identifier.urihttps://hdl.handle.net/11424/247743
dc.language.isoeng
dc.publisherIGI global
dc.relation.ispartofInternational Business: Concepts, Methodologies, Tools, and Applications
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.titleA structurationist analysis of differing policies oriented to the pharmaceutical industry: Turkey and Brazil
dc.typebookPart
dspace.entity.typePublication
oaire.citation.endPage1022
oaire.citation.startPage1001
oaire.citation.titleInternational Business: Concepts, Methodologies, Tools, and Applications

Files